Antibody‐based cancer therapy, one of the most significant therapeutic strategies, has
achieved considerable success and progress over the past decades. Nevertheless …

With the aim to efficiently develop and synthesize new radiotracers for PET imaging, and
their use for theranostic approaches, radiolabeling technics have not ceased to progress …

Protein therapeutics have gained momentum in recent years and become a pillar in treating
many diseases and the only choice in several ailments. Protein therapeutics are highly …

Click chemistry is universally recognized as a powerful strategy for the fast and precise
assembly of diverse building blocks. Targeted Protein Degradation (TPD) is a new …

Radioimmunotherapy (RIT) is FDA-approved for the clinical management of liquid
malignancies, however, its use for solid malignancies remains a challenge. The putative …

Bioorthogonal chemistry enables researchers to manipulate bioactive molecules in living
systems. These highly selective and biocompatible reactions can be carried out in various …

Extensive research on the synthesis and application of tetrazine derivatives for electronic
devices, luminescent elements, photoelectric conversion elements, and image sensors has …

Pretargeted PET imaging using bioorthogonal chemistry is a leading strategy for the tracking
of long-circulating agents such as antibodies and nanoparticle-drug delivery systems with …

Antibody-drug conjugates (ADCs) are a class of targeted therapeutic, typically used for the
treatment of cancers. By attaching drugs site-selectively to antibodies, off-target toxicity of the …

Hepatocellular carcinoma (HCC) is one of the top five most common malignant tumour types
in the western world. The asymptomatic nature of early stage HCC leads to an issue that …